Similarly, in nonalcoholic fatty liver disease in mice, there’s an upregulation of DDRGK1, UFM1, and UFM1-conjugated DDRGK1, contributing to increased UFMylation expression [40]. This evidence concerns the gene UFM1 and metabolic dysfunction-associated steatotic liver disease.